Michal A Olszewski Selected Research

Michal A Olszewski Research Topics

Disease

28	Infections 10/2021 - 09/2003
8	Cryptococcosis 10/2021 - 03/2007
5	Persistent Infection 12/2019 - 06/2008
4	Inflammation (Inflammations) 01/2021 - 02/2010
4	Invasive Fungal Infections 12/2019 - 03/2009
3	Mycoses (Diseases, Fungus) 10/2018 - 05/2011
3	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2012 - 06/2008
2	Meningoencephalitis 01/2020 - 01/2018
2	Pneumonia (Pneumonitis) 10/2014 - 09/2003
2	Fibrosis (Cirrhosis) 04/2013 - 10/2012
1	Disease Progression 01/2021
1	Brain Injuries (Brain Injury) 11/2017
1	Central Nervous System Infections (Central Nervous System Infection) 11/2017
1	Neoplasms (Cancer) 11/2017
1	Parasitic Diseases (Parasitic Disease) 01/2017
1	Peptic Ulcer (Peptic Ulcers) 10/2016
1	Coinfection 01/2016
1	Lung Injury 02/2014
1	Lung Diseases (Lung Disease) 04/2013
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2012
1	Cicatrix (Scar) 10/2012
1	Acute Lung Injury 01/2010
1	Metaplasia 12/2009
1	Encephalitis (Encephalitis, Rasmussen) 03/2009
1	Meningitis 03/2009
1	Fungemia 06/2008
1	Invasive Pulmonary Aspergillosis 03/2007
1	Human Influenza (Influenza) 09/2003

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 01/2020 - 09/2003
4	Diphtheria ToxinIBA 04/2013 - 09/2009
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2021 - 02/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2016
2	LigandsIBA 01/2021 - 01/2020
2	LipopolysaccharidesIBA 01/2020 - 01/2010
2	Chemokine ReceptorsIBA 01/2020 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 10/2018 - 10/2014
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2017 - 07/2013
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2016 - 03/2007
2	STAT1 Transcription FactorIBA 12/2015 - 10/2014
2	Interferon-gamma (Interferon, gamma)IBA 03/2014 - 02/2010
2	Interleukin-17 (Interleukin 17)IBA 03/2014 - 02/2010
2	CollagenIBA 04/2013 - 10/2012
2	Immunoglobulin E (IgE)IBA 12/2009 - 06/2008
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2021
1	CC ChemokinesIBA 01/2021
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020
1	AntigensIBA 12/2019
1	histone H3 trimethyl Lys4IBA 12/2019
1	Glycerol (Glycerine)FDA LinkGeneric 01/2018
1	Immune Checkpoint InhibitorsIBA 11/2017
1	ElementsIBA 01/2017
1	Metronidazole (Metric)FDA LinkGeneric 10/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Mitogen-Activated Protein KinasesIBA 01/2016
1	SmokeIBA 02/2014
1	PlasticsIBA 06/2013
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 04/2013
1	ChemokinesIBA 03/2013
1	PlasminogenIBA 10/2012
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2012
1	Protein CIBA 10/2012
1	Surface-Active Agents (Surfactants)IBA 10/2012
1	Plasminogen Activator Inhibitor 1IBA 10/2012
1	Complement System Proteins (Complement)IBA 10/2012
1	LaccaseIBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 05/2011
1	ArginaseIBA 05/2011
1	Mannose ReceptorIBA 02/2010
1	EndotoxinsIBA 01/2010
1	Interleukin-13IBA 12/2009
1	UreaseIBA 03/2009
1	Virulence Factors (Pathogenicity Factors)IBA 03/2009
1	Formaldehyde (Formol)FDA Link 09/2003
1	Immunoglobulin G (IgG)IBA 09/2003
1	AntibodiesIBA 09/2003
1	Immunoglobulin A (IgA)IBA 09/2003

Therapy/Procedure

5	Therapeutics 01/2021 - 09/2009
1	Immunomodulation 01/2017